FDA inspection and enforcement warning letters and inspections hit a multi-year high FDAs Center for Drug Evaluation and Research (CDER) issued 303 warning letters to drug and biologics manufacturers in fiscal year 2025, a 59% increase from 190 in FY 2024. Several factors are driving the increase: a return to full-scale inspection activity following the pandemic-era slowdown, a significant staff restructuring in spring 2025 that affected approximately 3,500 FDA employees (with some subsequently reinstated), and an intensified focus on data integrity and quality system failures across both domestic and foreign facilities. This is not the picture of an agency in retreat
Cardiovascular Health: Both components support cardiovascular health
Regularly check the expiration date, and if the capsules have expired, do not use them and dispose of them appropriately
For the Novo Nordisk Patient Assistance Program application, you must meet the following criteria: US residency You must be a U.S
Sure, OEM&ODM available
At a clinically-studied dose, Eriomin is shown to increase GLP-1 levels, support insulin function, and promote healthy blood glucose levels in the normal range